ARTICLE | Company News
A.P. Pharma, Paul Capital Partners deal
June 11, 2007 7:00 AM UTC
APPA received a $2.5 million milestone payment from Paul Capital's Paul Royalty Fund under a deal in which Paul Capital purchased royalty rights to acne drug Retin-A Micro and actinic keratosis drug ...